Variant report
Variant | esv3493292 |
---|---|
Chromosome Location | chr6:81851683-81855081 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368093148 | chr6:81853624-81853625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528520190 | chr6:81853642-81853643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551581980 | chr6:81853661-81853662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs77723330 | chr6:81853687-81853688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114552872 | chr6:81853728-81853729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146228174 | chr6:81853729-81853730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567294636 | chr6:81853731-81853732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs72897305 | chr6:81853748-81853749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185115051 | chr6:81853755-81853756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs144497126 | chr6:81853842-81853843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs75331812 | chr6:81853855-81853856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142964055 | chr6:81853869-81853870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549514843 | chr6:81853875-81853876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs9449248 | chr6:81853894-81853895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575490281 | chr6:81853898-81853899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190707521 | chr6:81853907-81853908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200327340 | chr6:81853918-81853919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554561456 | chr6:81853950-81853951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574634972 | chr6:81853958-81853959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114115853 | chr6:81853961-81853962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs528309603 | chr6:81853962-81853963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs117592738 | chr6:81853967-81853968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs368113992 | chr6:81853979-81853980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571499249 | chr6:81854003-81854004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531528851 | chr6:81854041-81854042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs79215423 | chr6:81854042-81854043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs77480944 | chr6:81854048-81854049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs397737590 | chr6:81854051-81854052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565183067 | chr6:81854054-81854055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs144319067 | chr6:81854087-81854088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551112143 | chr6:81854097-81854098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567863621 | chr6:81854125-81854126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530388302 | chr6:81854126-81854127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371514506 | chr6:81854135-81854136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546293017 | chr6:81854148-81854149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12665863 | chr6:81854169-81854170 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs148802609 | chr6:81854208-81854209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552301107 | chr6:81854209-81854210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs569116832 | chr6:81854249-81854250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537654743 | chr6:81854283-81854284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554703519 | chr6:81854290-81854291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371984297 | chr6:81854307-81854308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs181949238 | chr6:81854347-81854348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs73749048 | chr6:81854406-81854407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs142471843 | chr6:81854415-81854416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs151321798 | chr6:81854424-81854425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545138375 | chr6:81854426-81854427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs185725534 | chr6:81854493-81854494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs57186882 | chr6:81854497-81854498 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs575285361 | chr6:81854519-81854520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:81853600-81855800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr6:81854000-81854600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr6:81854000-81855200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |